e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study
El Solh A. A., Saliba R., Bosinski T., Grant B. J. B., Berbary E., Miller N.
Source:
Eur Respir J 2006; 27: 997-1002
Journal Issue:
May
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
El Solh A. A., Saliba R., Bosinski T., Grant B. J. B., Berbary E., Miller N.. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006; 27: 997-1002
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Sleep apnoea, hypertension and vascular disease: where are we now?
Source: Eur Respir Rev 2007; 16: 169-182
Year: 2007
Obstructive sleep apnoea: who should be treated?
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005
The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013
Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
Source: Eur Respir J 2009; 33: 1062-1067
Year: 2009
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea
Source: Eur Respir J 2011; 37: 873-879
Year: 2011
Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017
Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea
Source: Eur Respir J 2012; 39: 913-918
Year: 2012
Treatment effects of sleep apnoea: where are we now?
Source: Eur Respir Rev 2007; 16: 146-168
Year: 2007
The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial.
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP
versus
nasal strips
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea
Source: Eur Respir J 2009; 34: 1390-1398
Year: 2009
Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018
Year: 2018
A prospective polysomnographic study on the evolution of complex sleep apnoea
Source: Eur Respir J 2011; 38: 329-337
Year: 2011
A noninvasive device to measure endothelial dysfunction and its response to CPAP treatment in obstructive sleep apnoea patients
Source: Annual Congress 2008 - Diagnostic aspects of sleep apnoea
Year: 2008
Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial
Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019
Year: 2020
Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients
Source: Annual Congress 2005 - Control of breathing
Year: 2005
Obstructive sleep apnoea severity and endothelial dysfunction: a meta-analysis of individual patient data.
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019
The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept